FindTrial
Sign In

CLINICAL TRIAL TO STUDY THE EFFECT OF NAVAK GUGGULU IN BAL STHAULYA

CLINICAL STUDY TO EVALUATE THE EFFICACY OF NAVAK GUGGULU IN BAL STHAULYA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026426
Enrollment
40
Registered
2020-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: navaka guggulu: 100 mg single vati of Two divided doses after breakfast and after dinner will be given for 60 days that will be increased according to age up to 16 years There will be t

Sponsors

rishikul campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age: 5 yr to 16 yr overweight and obesity

Exclusion criteria

Exclusion criteria: children below 5 yr and above 16 year Children with Hypothyroidism & Cushing syndrome Children with long term Steroid treatment Children with Hepatic pathologic involvement Children with congenital Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
clinical study to evaluate the efficacy of navaka guggulu in bal sthaulya subjectively all signs and symptoms are given with grading depending upon their severityTimepoint: 8 weeks—

Secondary

MeasureTime frame
exacerbation in signs and symptomsTimepoint: 15 days—

Countries

India

Contacts

Public ContactDr Keerti Verma

rishikul campus

keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026